<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: Malattie rare, Russo (Aifa): &#8220;In Italia alta percentuale di farmaci accessibili ai pazienti&#8221; ‘Finanziati studi per 17 mln e mezzo relativi a terapie avanzate, cellulari e geniche’	</title>
	<atom:link href="https://www.lafrecciaweb.it/2026/07/02/malattie-rare-russo-aifa-in-italia-alta-percentuale-di-farmaci-accessibili-ai-pazienti-finanziati-studi-per-17-mln-e-mezzo-relativi-a-terapie-avanzate-cellulari-e-geniche/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.lafrecciaweb.it/2026/07/02/malattie-rare-russo-aifa-in-italia-alta-percentuale-di-farmaci-accessibili-ai-pazienti-finanziati-studi-per-17-mln-e-mezzo-relativi-a-terapie-avanzate-cellulari-e-geniche/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=malattie-rare-russo-aifa-in-italia-alta-percentuale-di-farmaci-accessibili-ai-pazienti-finanziati-studi-per-17-mln-e-mezzo-relativi-a-terapie-avanzate-cellulari-e-geniche</link>
	<description>la velocità dell&#039;informazione</description>
	<lastBuildDate>Thu, 02 Jul 2026 14:22:00 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
